| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Murphy MF | |
| Brunskill S | |||
| Hyde C | |||
| Stanworth SJ | |||
| P2860 | cites work | Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation | Q24245960 |
| An interlaboratory study of a candidate reference method for platelet counting | Q32170524 | ||
| Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial | Q33329515 | ||
| Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions | Q33340587 | ||
| What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? | Q33342383 | ||
| Guidelines for the use of platelet transfusions | Q33348675 | ||
| Prophylactic platelet transfusions: which dose is the best dose? A review of the literature | Q33349172 | ||
| Measurement of bleeding severity: a critical review | Q33360118 | ||
| Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial | Q33360736 | ||
| Relationship between platelet count and bleeding risk in thrombocytopenic patients | Q33361658 | ||
| The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study | Q33362605 | ||
| Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion | Q33364794 | ||
| Compliance with prophylactic platelet transfusion trigger in haematological patients | Q33365020 | ||
| Controversies in platelet transfusion therapy | Q33483395 | ||
| The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Q33501152 | ||
| New strategies for prophylactic platelet transfusion in patients with hematologic diseases | Q34417190 | ||
| The effectiveness of interventions to reduce physician's levels of inappropriate transfusion: what can be learned from a systematic review of the literature. | Q34996017 | ||
| Risks associated with transfusion of cellular blood components in canada | Q35122220 | ||
| Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. | Q35131637 | ||
| Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers. | Q40494663 | ||
| Appropriateness and safety of blood transfusion | Q42722048 | ||
| Platelet counting by the RBC/platelet ratio method. A reference method | Q43541290 | ||
| Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes | Q44903709 | ||
| Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design. | Q51982891 | ||
| Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers. | Q52866928 | ||
| THE RELATION OF BLOOD PLATELETS TO HEMORRHAGIC DISEASE | Q54107270 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | platelet transfusion | Q23925170 |
| P304 | page(s) | 588-595 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? | |
| P478 | volume | 131 |
| Q24198288 | A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation |
| Q24186913 | A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
| Q33438003 | Bleeding After Endoscopic Procedures in Patients With Chronic Hematologic Thrombocytopenia |
| Q46573703 | Clinical Trial Opportunities in Transfusion Medicine: Proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium |
| Q39025446 | Clinical and quality evaluation of apheresis vs random-donor platelet concentrates stored for 7 days |
| Q24198832 | Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation |
| Q24186359 | Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
| Q30496886 | Dose of prophylactic platelet transfusions and prevention of hemorrhage |
| Q33394232 | Factors determining the risk of severe (WHO grades 3 and 4) hemorrhage in hematologic patients |
| Q64232456 | How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa |
| Q36393468 | How to further develop the evidence base for transfusion medicine |
| Q27023734 | Indications for platelet transfusion in patients with thrombocytopenia |
| Q33422414 | Interference of blast cell fragments with automated platelet counting |
| Q37417311 | Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party. |
| Q43755901 | National comparative audit of the use of platelet transfusions in the UK. |
| Q33395035 | Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia |
| Q38909287 | Peridischarge prophylactic platelet transfusions after stem cell transplant: is a tranfusion trigger needed? |
| Q56505470 | Platelet transfusions |
| Q33376399 | Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L. |
| Q24197779 | Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation |
| Q33436425 | Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q39230265 | Seasonal variation and predictors of epistaxis |
| Q33402744 | Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study |
| Q40051537 | Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients |
Search more.